News & Events May

CTI Announces Completes Enrollment of Phase II Trial in the US with YSPSL for Prevention of Delayed Graft Function in Renal Transplantation

May 7, 2007

Preliminary Results Presented at the 2007 American Transplant Congress CTI Clinical Trial and Consulting Services (CTI) announced the completion of patient enrollment in a Phase II clinical trial of YSPSL for prevention of delayed graft function (DGF) in kidney transplant patients. YSPSL is a recombinant molecule resulting from the ...

Read More

Join Our Mailing List